Epstein Secrets

nd, VA (7/28, 29K) reported White House Coronavirus Task Force Response Coordinator Deborah Birx visited Richmond Tuesday to meet with Virginia Gov. Ralph Northam (D) and state health officials. Birx "gave some recommendations to possibly help mitigate this upward trend in numbers. Among those recommendations

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

nd, VA (7/28, 29K) reported White House Coronavirus Task Force Response Coordinator Deborah Bin( visited Richmond Tuesday to meet with Virginia Gov. Ralph Northam (D) and state health officials. Birx "gave EFTA00136240 some recommendations to possibly help mitigate this upward trend in numbers. Among those r

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

nd, VA (7/28, 29K) reported White House Coronavirus Task Force Response Coordinator Deborah Birx visited Richmond Tuesday to meet with Virginia Gov. Ralph Northam (D) and state health officials. Birx "gave some recommendations to possibly help mitigate this upward trend in numbers. Among those recommendations

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U

nd, VA (7/28, 29K) reported White House Coronavirus Task Force Response Coordinator Deborah Birx visited Richmond Tuesday to meet with Virginia Gov. Ralph Northam (D) and state health officials. Birx "gave some recommendations to possibly help mitigate this upward trend in numbers. Among those recommendations

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U